Multifocality Appears to Increase Risk of Recurrence in Papillary Thyroid Carcinoma
The risk of recurrence varied by patient age, tumor size, and number of foci.
Diagnosis & Disease Information
Study Reveals Less Toxic Induction Regimen for High-Risk Neuroblastoma
The rCOJEC regimen was less toxic than the MSKCC-N5 regimen.
Response Endpoints Deemed ‘Poor Surrogates’ for Overall Survival in Trials of Immune Checkpoint Inhibitors
Response endpoints were not strongly correlated with overall survival at the trial level.
Vandetanib and Cabozantinib Deemed Effective in Real-World Study of Medullary Thyroid Cancer
The overall survival rate at 1 year was 86% with vandetanib and 70% with cabozantinib.
Local Resection Is ‘Sufficient’ for Parathyroid Carcinoma
Patients with parathyroid carcinoma after localized resection for a presumed benign indication should undergo close monitoring for recurrence rather than radical surgery.
Lenvatinib Produces ‘Strong’ Responses in Resistant Gastroenteropancreatic Neuroendocrine Tumors
The response rate was higher for patients with pancreatic NETs than for those with gastrointestinal NETs.
Mutational Risk Not Associated With Distant Metastasis in Medullary Thyroid Cancer
Researchers identified risk factors for distant metastasis in sporadic and hereditary medullary thyroid cancer.
Cabozantinib Gets Breakthrough Tx Status for Differentiated Thyroid Cancer
The designation is supported by data from the randomized, double-blind, placebo-controlled phase 3 COSMIC-311 study.
Exposure to Light at Night May Increase Risk for Thyroid Cancer
Investigators tested the hypothesis that greater exposure to light at night (LAN) is associated with an increased risk for thyroid cancer by studying artificial outdoor LAN measured by satellite imagery in relation to thyroid cancer.
Artificial Light at Night Tied to Thyroid Cancer Risk
Positive association mainly driven by incidence of papillary thyroid cancer.
- Loading...
Loading...
Next post in Pancreatic Cancer
Loading... 
Loading...